Literature DB >> 17726036

The expression of SOCS is altered in rheumatoid arthritis.

P Isomäki1, T Alanärä, P Isohanni, A Lagerstedt, M Korpela, T Moilanen, T Visakorpi, O Silvennoinen.   

Abstract

OBJECTIVES: Cytokines play a key pathogenic role in rheumatoid arthritis (RA). Several cytokines signal through the JAK-STAT pathway, which is negatively regulated by the suppressors of cytokine signalling (SOCS) proteins. Since SOCS protein levels can profoundly modulate cellular responses to cytokines, we have investigated their expression in chronic RA.
METHODS: The levels of SOCS1-3 and CIS1 mRNA in peripheral blood (PB) and synovial fluid (SF) mononuclear cells (MCs), purified T cells and monocytes from RA patients and healthy volunteers were studied using quantitative reverse transcriptase polymerase chain reaction (RT-PCR). SOCS mRNA and protein expression in synovial tissues were examined by RT-PCR and immunohistochemistry.
RESULTS: The levels of SOCS1 and SOCS3 were significantly increased in PBMCs from RA patients when compared with healthy volunteers. These differences were mainly due to up-regulation of SOCS1 in PB T cells and of SOCS3 in PB monocytes. In addition, SOCS2 was up-regulated in PB T cells. Interestingly, SF T cells expressed lower and SF macrophages higher levels of SOCS molecules than their PB counterparts. Similarly, while a significant portion of macrophages in synovial tissues expressed SOCS1 and SOCS3 proteins, the majority of T cells remained SOCS negative. Finally, SOCS1 was up-regulated in the synovial membranes from patients with RA when compared with osteoarthritis.
CONCLUSIONS: SOCS expression levels are profoundly altered in RA, and the profile of SOCS expression is dependent on both the cell type as well as the cellular compartment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726036     DOI: 10.1093/rheumatology/kem198

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  32 in total

1.  Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production.

Authors:  Erica L Scheller; Kurt D Hankenson; Jayne S Reuben; Paul H Krebsbach
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

2.  Effects of miR-150-5p on the growth and SOCS1 expression of rheumatoid arthritis synovial fibroblasts.

Authors:  Mingliang Qiu; Lisha Mo; Juxiang Li; Hua Liang; Weina Zhu; Xiangjuan Zheng; Xinwang Duan; Weidong Xu
Journal:  Clin Rheumatol       Date:  2019-12-26       Impact factor: 2.980

3.  DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.

Authors:  Denise C Andia; Aline C Planello; Danielle Portinho; Rodrigo A da Silva; Cristiane R Salmon; Enilson A Sallum; Francisco H Nociti Junior; Ana P de Souza
Journal:  Clin Oral Investig       Date:  2015-04-07       Impact factor: 3.573

4.  Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.

Authors:  Shih-Yao Chen; Ming-Fei Liu; Pin-Yu Kuo; Chrong-Reen Wang
Journal:  Clin Rheumatol       Date:  2019-02-15       Impact factor: 2.980

Review 5.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

6.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

7.  The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Jeng-Ting Tsao; Chia-Chen Kuo; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2008-09-27       Impact factor: 3.984

8.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

9.  Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum.

Authors:  Uta Bussmeyer; Arup Sarkar; Kirsten Broszat; Tanja Lüdemann; Sonja Möller; Ger van Zandbergen; Christian Bogdan; Martina Behnen; J Stephen Dumler; Friederike D von Loewenich; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

10.  Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.

Authors:  Michael Walther; David Jeffries; Olivia C Finney; Madi Njie; Augustine Ebonyi; Susanne Deininger; Emma Lawrence; Alfred Ngwa-Amambua; Shamanthi Jayasooriya; Ian H Cheeseman; Natalia Gomez-Escobar; Joseph Okebe; David J Conway; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.